<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82250">
  <stage>Registered</stage>
  <submitdate>31/08/2007</submitdate>
  <approvaldate>12/09/2007</approvaldate>
  <actrnumber>ACTRN12607000462482</actrnumber>
  <trial_identification>
    <studytitle>Fluid Responsiveness in Septic Shock</studytitle>
    <scientifictitle>To assess the change in cardiac output from clinical fluid challenge in patients with septic shock.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Septic shock.</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Other cardiovascular diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Clinically administered fluid challenge (250mL colloid intravenous infusion over 15 minutes at request of treating clinician).
Participation in each study will take approximately 30 minutes of participant time.</interventions>
    <comparator>Nil.</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Correlation between baseline variables and subsequent increase in cardiac output (measured by USCOM).</outcome>
      <timepoint>Immediateley before and after fluid challenge.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Increase in cardiac output (measured by USCOM) of equal to or greater than 15%.</outcome>
      <timepoint>Immediately after fluid challenge.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Intensive care unit patients diagnosed with septic shock where fluid challenge is clinically requested.
Septic shock will be defined in terms of the International Sepsis Definitions Conference [American College of Chest Physicians/Society of Critical Care Medicine
Consensus Conference: definitions for sepsis and organ failure and guidelines
for the use of innovative therapies in sepsis. Crit Care Med 1992;20(6):864-74].</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>-2147483648</inclusivemaxage>
    <inclusivemaxagetype>N/A</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Treating clinician or patient/legally authorised representative decline participation/consent. Age &lt;18 years at time of eligibility, presence of moderate to severe valve disease, evidence of fluid overload (such as impaired gas exchange or radiographic evidence of pulmonary oedema).</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Natural history</purposeobs>
    <duration>Longitudinal</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>31/08/2007</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>30</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of Queensland</primarysponsorname>
    <primarysponsoraddress>The University of Queensland
Brisbane QLD 4072</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Other</fundingtype>
      <fundingname>Australian And New Zealand College of Anaesthetists</fundingname>
      <fundingaddress>Australian And New Zealand College of Anaesthetists (ANZCA) House
630 St Kilda Road
Melbourne VIC 3004</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Wesley Hospital</sponsorname>
      <sponsoraddress>451 Coronation Drive  
Auchenflower QLD 4066</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Uniting Healthcare Human Research Ethics Committee</ethicname>
      <ethicaddress>451 Coronation Drive  
Auchenflower QLD 4066</ethicaddress>
      <ethicapprovaldate>22/06/2007</ethicapprovaldate>
      <hrec>2007/36</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr David Sturgess</name>
      <address>451 Coronation Drive  
Auchenflower QLD 4066</address>
      <phone>+61 7 32327000</phone>
      <fax />
      <email>s3316247@student.uq.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr David Sturgess</name>
      <address>451 Coronation Drive  
Auchenflower QLD 4066</address>
      <phone>+61 7 32327000</phone>
      <fax />
      <email>s3316247@student.uq.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>